The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating …
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png00Stevehttps://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.pngSteve2021-02-26 19:57:142021-02-26 19:57:14Is Inflarx NV (IFRX) a Stock to Watch After Losing -25.84% This Week?
0replies
Leave a Reply
Want to join the discussion? Feel free to contribute!
Leave a Reply
Want to join the discussion?Feel free to contribute!